Wingstop Shares Tumble 12 as Earnings Miss Market Expectations Fanatics Strengthens Position as FIFAs Exclusive Collectibles Licensee Capturing Growing Market Amid Controversy Fed Rate Cut Prospects Dim as Jobs Report Highlights Sticky Inflation Pressures CRISPR Therapeutics Releases First Quarter 2026 Results Key Updates on Gene Editing Pipeline Fidelity to Impose Transaction Fee Up to 100 on Certain ETF Purchases Revealing the Hidden Costs of Custody Amazon UK Chief Urges Shift in Blaming Youth for Unemployment Points to Education System Gaps WS Q1 2026 Earnings EPS Falls Short of Estimates Stock Declines JAGX Q1 2026 Earnings Significant EPS Miss Highlights Operational Challenges Halozyme Therapeutics Inc HALO Q1 2026 Earnings EPS Surpasses Estimates Despite Flat Revenue Disclosure BDCI Q1 2026 Earnings Positive EPS of 005 Reported Despite Absence of Revenue Details VSCO Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response INVH Q1 2026 Earnings Strong EPS Beat Fails to Boost Sentiment as Stock Edges Lower Neuronetics STIM Rallies 2 as Shares Test Key Resistance Levels Ultrapar Participacoes UGP Edges Lower Support Levels Under Scrutiny Radiopharm Theranostics RADX Holds Steady at 449 Consolidation Phase for Radiopharma Play Spok Holdings SPOK Edges Lower Testing Support Zone Amid Low Volatility Catalyst Bancorp Inc CLST Edges Higher in Modest Uptrend MDXHealth Q1 2026 Earnings EPS Miss Weighs on Shares as Company Navigates Diagnostic Market enCore Energy Corp EU Q1 2026 Earnings Surprise Profit Driven by Strong Uranium Sales DPRO Q1 2026 Earnings EPS Misses Estimates by Narrow Margin Stock Gains on Optimism Around Operational Progress FRSX Q3 2021 Earnings NarrowerThanExpected Loss Drives Positive Market Response PDLB Q4 2025 Earnings EPS Surges Past Estimates Revenue Details Withheld CDIO Q1 2025 Earnings Narrowed Loss Beats Estimates Significantly MarketSmith India Unveils Top Stock Picks for May 27 Session VREX Q1 2026 Earnings EPS Barely Misses Estimates as Stock Edges Lower DarkIris Inc DKI Hovers Near Support as Selling Pressure Eases